FDA Panel Votes to Recommend More Restrictions on Hydrocodone Combos

Generic Line
An FDA advisory panel voted 19–10 Friday to recommend up-scheduling hydrocodone combination products to schedule II controlled substances, a move that would bring tighter restrictions on the opioid painkillers.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00